Literature DB >> 7537226

Expression and functional properties of the second predicted nucleotide binding fold of the cystic fibrosis transmembrane conductance regulator fused to glutathione-S-transferase.

C Randak1, A A Roscher, H B Hadorn, I Assfalg-Machleidt, E A Auerswald, W Machleidt.   

Abstract

CFTR-NBF-2 was expressed in Escherichia coli in fusion with glutathione-S-transferase, the soluble portion was purified and identified as a structured protein by its CD spectrum. Association reactions of the recombinant NBF-2 with adenine nucleotides were monitored qualitatively by demonstrating its ability to bind specifically to ATP-, ADP- and AMP-affinity agarose and quantitatively by recording the fluorescence enhancement of excited trinitrophenol (TNP)-labelled adenine nucleotides occurring as a result of binding to NBF-2. Best-fit monophasic binding curves to the fluorescence data indicated Kd values of 22 microM for TNP-ATP, 39 microM for TNP- ADP and 2.1 microM for TNP-AMP. The corrected Kd values for unlabelled adenine nucleotides competing with the fluorophores were determined to be 37 microM for ATP, 92 microM for ADP and 12 microM for AMP. The recombinant NBF-2 did not show any hydrolytic activity on ATP (detection limit 0.001 s-1). Our findings support the concept of a central role of NBF-2 in CFTR activity regulation acting as an allosteric switch between channel opening and closing and give the first experimental evidence that the channel inhibitor AMP could act via NBF-2.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7537226     DOI: 10.1016/0014-5793(95)00314-y

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Inhibition of ATPase, GTPase and adenylate kinase activities of the second nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator by genistein.

Authors:  C Randak; E A Auerswald; I Assfalg-Machleidt; W W Reenstra; W Machleidt
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

Review 2.  Frontiers in research on cystic fibrosis: understanding its molecular and chemical basis and relationship to the pathogenesis of the disease.

Authors:  Y H Ko; P L Pedersen
Journal:  J Bioenerg Biomembr       Date:  1997-10       Impact factor: 2.945

3.  Expression and purification of the first nucleotide-binding domain and linker region of human multidrug resistance gene product: comparison of fusions to glutathione S-transferase, thioredoxin and maltose-binding protein.

Authors:  C Wang; A F Castro; D M Wilkes; G A Altenberg
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

4.  A recombinant peptide model of the first nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator: comparison of wild-type and delta F508 mutant forms.

Authors:  I Yike; J Ye; Y Zhang; P Manavalan; T A Gerken; D G Dearborn
Journal:  Protein Sci       Date:  1996-01       Impact factor: 6.725

Review 5.  CFTR (ABCC7) is a hydrolyzable-ligand-gated channel.

Authors:  Andrei A Aleksandrov; Luba A Aleksandrov; John R Riordan
Journal:  Pflugers Arch       Date:  2006-09-26       Impact factor: 3.657

Review 6.  Cystic fibrosis: channel, catalytic, and folding properties of the CFTR protein.

Authors:  F S Seibert; T W Loo; D M Clarke; J R Riordan
Journal:  J Bioenerg Biomembr       Date:  1997-10       Impact factor: 2.945

7.  Functional analysis of the C-terminal boundary of the second nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator and structural implications.

Authors:  Martina Gentzsch; Andrei Aleksandrov; Luba Aleksandrov; John R Riordan
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

Review 8.  Role of CFTR's intrinsic adenylate kinase activity in gating of the Cl(-) channel.

Authors:  Christoph O Randak; Michael J Welsh
Journal:  J Bioenerg Biomembr       Date:  2007-12       Impact factor: 2.945

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.